Effectiveness of human epididymis protein 4 (HE4) as predictor of response to first line platinum based chemotherapy

Plotti Francesco,BartoloneMartina,Terranova Corrado,Guzzo Federica,DE Cicco Nardone Carlo,M. Roberto,MolinaroMichele,CiccozziMassimo,BenvenutoDomenico,Di Donato Violante,Benedetti Panici Pierluigi,Angioli Roberto

Published 2021 in European Journal of Gynaecological Oncology

ABSTRACT

Objective: To assess the role of HE4 (Human epidydimal protein 4) marker as predictor of response to platinum based chemotherapy. Methods: In the current observational prospective study, 35 patients affected by High Grade Serous Ovarian Cancer (HGSOC) were enrolled; among these, 17 patients were platinum sensitive, while 18 were platinum resistant. HE4 levels were measured before surgery, at the III and at the VI cycle of chemotherapy. Results: The reduction of 50% or more of HE4 levels at the III cycle of chemotherapy showed a specificity of 100% and a sensitivity of 27%. The negativization (<70 pmol/L) of HE4 at the III cycle of chemotherapy showed a specificity of 100%, with a sensitivity of 39%, in predicting chemotherapy response, while the same parameter at the VI cycle showed a specificity of 82% and a sensitivity of 67%. Moreover the ROC analysis identified the HE4 cut-off value of 62.79 pmol/L as the best cut-off in predicting chemotherapy response, with a sensitivity of 72% and a specificity of 88% at the III cycle. Discussion: Our results suggest that HE4 levels during first-line chemotherapy, in particular at the III cycle, could predict chemotherapy response in HGSOC patients.

PUBLICATION RECORD

  • Publication year

    2021

  • Venue

    European Journal of Gynaecological Oncology

  • Publication date

    Unknown publication date

  • Fields of study

    Not labeled

  • Identifiers
  • External record

    Open on Semantic Scholar

  • Source metadata

    Semantic Scholar

CITATION MAP

EXTRACTION MAP

CLAIMS

  • No claims are published for this paper.

CONCEPTS

  • No concepts are published for this paper.

REFERENCES

Showing 1-41 of 41 references · Page 1 of 1

CITED BY

  • No citing papers are available for this paper.

Showing 0-0 of 0 citing papers · Page 1 of 1